IOL Chemicals and Pharmaceuticals Limited (NSE:IOLCP)
India · Delayed Price · Currency is INR 100.17
-2.99 (-2.90%)
Aug 1, 2025, 3:30 PM IST
IOL Chemicals and Pharmaceuticals Employees
IOL Chemicals and Pharmaceuticals had 2,777 employees as of March 31, 2024. The number of employees increased by 208 or 8.10% compared to the previous year.
Employees
2,777
Change (1Y)
208
Growth (1Y)
8.10%
Revenue / Employee
$7,192,010
Profits / Employee
$349,602
Market Cap
29.44B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 2,777 | 208 | 8.10% |
| Mar 31, 2023 | 2,569 | 253 | 10.92% |
| Mar 31, 2022 | 2,316 | 247 | 11.94% |
| Mar 31, 2021 | 2,069 | 318 | 18.16% |
| Mar 31, 2020 | 1,751 | 133 | 8.22% |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 43,000 |
| Divi's Laboratories | 10,542 |
| Cipla | 30,313 |
| Mankind Pharma | 26,978 |
| Apollo Hospitals Enterprise | 83,147 |
| Zydus Lifesciences | 27,917 |
| Fortis Healthcare | 12,237 |
| Aurobindo Pharma | 26,015 |
IOL Chemicals and Pharmaceuticals News
- 3 months ago - IOL Chemicals and Pharmaceuticals shares jump nearly 5% after China approves Ibuprofen export - Business Upturn
- 3 months ago - Why are IOL Chemicals share price falling 3% today? Check here - Business Upturn
- 5 months ago - IOL Chemicals shares surge 4% after EDQM certification for Quetiapine Fumarate - Business Upturn
- 7 months ago - IOL Chemicals and Pharmaceuticals shares rise nearly 4% as board approves 1:5 stock split - Business Upturn
- 8 months ago - IOL Chemicals shares surge 7% after company plans to consider stock split - Business Upturn
- 9 months ago - IOL Chemicals & Pharmaceuticals shares fall nearly 5% after disappointing Q2 FY25 results - Business Upturn